MétaCan
Menu
Back to cohort
Record W4306701188 · doi:10.1097/qad.0000000000003405

Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV

2022· article· en· W4306701188 on OpenAlexafffundabout
Catharine Chambers, Hasina Samji, Curtis Cooper, Cecilia T. Costiniuk, Naveed Z. Janjua, Abigail Kroch, Gordon Arbess, Anita C. Benoit, Sarah A. Buchan, Hannah Chung, Claire Kendall, Jeffrey C. Kwong, Marc‐André Langlois, Samantha Lee, Lawrence Mbuagbaw, John McCullagh, Rahim Moineddin, Devan Nambiar, Sharon Walmsley, Aslam H. Anis, Ann N. Burchell

Bibliographic record

VenueAIDS · 2022
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsMcMaster UniversitySt. Joseph’s Healthcare HamiltonImpactWomen's College HospitalBruyèreOntario HIV Treatment NetworkHIV Legal NetworkUniversity of OttawaInstitute for Clinical Evaluative SciencesMcGill University Health CentreSimon Fraser UniversityUniversity Health NetworkOttawa HospitalThe Scarborough HospitalPublic Health OntarioUniversity of British ColumbiaSt. Michael's HospitalBC Centre for Disease ControlUniversity of Toronto
FundersDepartment of Family and Community Medicine, University of TorontoFonds de Recherche du Québec - SantéCanadian Institutes of Health ResearchCanadian Immunization Research NetworkUniversity of TorontoUniversity of OttawaPublic Health AgencyPublic Health Agency of Canada
KeywordsMedicineHuman immunodeficiency virus (HIV)CohortVirologyPopulationCohort studyCoronavirus disease 2019 (COVID-19)DiseaseCoronavirusEnvironmental healthGerontologyInternal medicineInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

OBJECTIVE: People with HIV were underrepresented in coronavirus disease 2019 (COVID-19) vaccine clinical trials. We estimated vaccine effectiveness (VE) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection for the BNT162b2, mRNA-1273, and ChAdOx1 vaccines among a population-based cohort of people with HIV in Ontario, Canada. DESIGN: Test-negative design. METHODS: We identified people with HIV aged ≥19 years who were tested for SARS-CoV-2 by RT-PCR between December 14, 2020 (first availability of COVID-19 vaccines) and November 21, 2021 (pre-Omicron circulation). Outcomes included any infection, symptomatic infection, and COVID-19-related hospitalization/death. We compared the odds of vaccination between test-positive cases and test-negative controls using multivariable logistic regression with adjustment for age, sex, region, calendar time, SARS-CoV-2 test histories, influenza vaccination, comorbidities, and neighborhood-level socio-economic status. VE was derived as (1 - adjusted odds ratio) × 100%. RESULTS: Among 21 023 adults living with HIV, there were 801 (8.3%) test-positive cases and 8,879 (91.7%) test-negative controls. 20.1% cases and 47.8% of controls received ≥1 COVID-19 vaccine dose; among two-dose recipients, 93.4% received ≥1 mRNA dose. Two-dose VE ≥7 days before specimen collection was 82% (95% confidence interval [CI] = 74-87%) against any infection, 94% (95% CI = 82-98%) against symptomatic infection, and 97% (95% CI = 85-100%) against hospitalization/death. Against any infection, VE declined from 86% (95% CI = 77-92%) within 7-59 days after the second dose to 66% (95% CI = -15-90%) after ≥180 days; we did not observe evidence of waning protection for other outcomes. CONCLUSION: Two doses of COVID-19 vaccine offered substantial protection against symptomatic illness and hospitalization/death in people with HIV prior to the emergence of the Omicron variant. Our findings do not support a broad conclusion that COVID-19 VE is lower among people with HIV in populations that, for the most part, are attending HIV care, taking antiretroviral medication, and are virally suppressed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.425

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.326
Teacher spread0.307 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2022
Admission routes3
Has abstractyes

Explore more

Same venueAIDSSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207